D
Bristol-Myers Squibb Company BMY
$59.01 -$1.27-2.11%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -94.05% -27.92% 114.10% -775.99% -8.61%
Total Depreciation and Amortization -29.75% 0.30% 6.23% 0.86% -0.93%
Total Amortization of Deferred Charges -- -- -200.00% -- --
Total Other Non-Cash Items 2,929.27% -90.26% -96.51% 1,580.22% -1,456.67%
Change in Net Operating Assets -25.25% 171.99% -1,297.47% -76.84% 193.81%
Cash from Operations -20.60% 140.37% -17.93% -33.35% -10.50%
Capital Expenditure -16.67% -23.66% 7.75% 13.94% 3.51%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions 86.49% 74.65% 93.15% -3,351.46% -78.22%
Divestitures 30.59% -5.56% 12.03% 0.00% -2.43%
Other Investing Activities -152.53% 330.43% -90.38% 170.71% -6,245.45%
Cash from Investing 10.50% 83.40% 93.28% -1,357.50% -228.29%
Total Debt Issued -526.32% -70.86% -97.96% 277.85% 42,320.00%
Total Debt Repaid 100.00% 12.12% -- -- --
Issuance of Common Stock -- -- -- -- 1,150.00%
Repurchase of Common Stock -- -- -- -- 100.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -0.16% 0.08% -0.41% -4.48% 2.60%
Other Financing Activities -218.75% 366.67% 93.81% -- --
Cash from Financing 57.37% 4.25% -127.47% 1,414.37% 118.74%
Foreign Exchange rate Adjustments -290.91% 450.00% 51.11% -157.69% 305.26%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 53.66% 152.57% -39.04% -155.30% 561.03%
Weiss Ratings